SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-187758
Filing Date
2014-05-07
Accepted
2014-05-07 17:24:23
Documents
3
Period of Report
2014-05-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d721714d8k.htm 8-K 15926
2 EX-1.1 d721714dex11.htm EX-1.1 9652
3 EX-5.1 d721714dex51.htm EX-5.1 4228
  Complete submission text file 0001193125-14-187758.txt   31103
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 14822126
SIC: 2834 Pharmaceutical Preparations